Bernd Schaden serves as Director, Supply Chain, CMC at Hemab. He has more than 25 years of Supply Chain experience in the pharmaceutical industry in managing and leading many aspects of supply chain. Starting with the commercial supply chain at Eli Lilly Austria, moving to Baxter/Baxalta’s Global Clinical Supply Chain team, where he was involved in all the development stages from their entire pipeline which had a strong focus on rare bleeding disorders. After leading the transition of this portfolio to Shire, he spent the last 5 years as Director, Global Supply Chain Launch Excellence, where he led was leading a team supporting more than 100 commercial launches of more than 15 products covering multiple therapeutic areas in more than 50 countries. He earned a Master's Degree in Business Administration, specialising in Supply Chain Management, from the Vienna University of Economics and Business in Austria.

‍